Entero Healthcare Solutions Ltd
Entero Healthcare Solutions Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Targeting 30% revenue growth in FY'26, combining both organic and inorganic growth. - Organic growth remains strong at around 15%, with inorganic contributing approximately 16%, summing to a like-for-like growth of 31%. - Acquisitions expected to contribute about Rs. Entero Healthcare Solutions targets 30% revenue growth in FY'26, combining organic and inorganic growth. - EBITDA margin guidance is 4%+ for the full year FY'26, with current Q1 margin at 3.6% expected to improve as revenue growth accelerates. - Operating leverage benefits will drive margin expansion as fixed costs are stable; salary hikes are already accounted for in Q1. - Gross margins improved by 83 bps YoY to 9.9%, with further procurement efficiencies and richer product mix expected. - Profit after tax increased 47% YoY to Rs.
From Entero Healthcare Solutions Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Targeting 30% revenue growth in FY'26, combining both organic and inorganic growth.
- Organic growth remains strong at around 15%, with inorganic contributing approximately 16%, summing to a like-for-like growth of 31%.
- Acquisitions expected to contribute about Rs. 500 crores in revenue this year, supporting inorganic growth.
- Rate of acquisitions likely to taper off in the next 2-3 years as market penetration and product expansion mature.
- Expansion into higher-margin categories like medical devices, diagnostics, and specialty pharma to drive richer product mix and incremental growth.
- Deepening wallet share with existing customers by expanding product range and geographic presence.
2 more points from Entero Healthcare Solutions Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Entero Healthcare Solutions Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Entero Healthcare has already made significant investments in proprietary technology, including building its own customizable ERP systems integrated with platforms like Facebook and WhatsApp, and customer-facing apps.
- They are also developing a health tech platform to integrate directly with retailer systems.
- Most technology infrastructure investments are already in place, so no significant additional capex is expected in technology going forward.
- Future focus will be on better utilization and capitalization of existing technology to drive efficiencies such as working capital reduction.
- The company is actively pursuing acquisitions (M&A) to expand geographic presence and product offerings, with 4 acquisitions in the pipeline and more deals being evaluated.
2 more points from Entero Healthcare Solutions Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Retailing
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Entero Healthcare Solutions Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders in numeric terms.
- However, regarding acquisitions (which can be linked to future orderbook/revenue), the company targets about Rs. 500 crores of recognized acquisition revenue for the year.
- Four acquisition deals are in the pipeline; two already closed with revenue starting to flow from Q2, and two pending closure dependent on external factors like drug licenses.
- Additional deals beyond these four are under evaluation, with announcements expected within the next month.
2 more points from Entero Healthcare Solutions Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Entero Healthcare Solutions Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.9K Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Entero Healthcare Solutions Ltd's management said in earlier quarters
Others in Retailing this season
- Trent Ltd (Q1 FY26)
Q1 FY26 Revenue from operations (Standalone): ₹4,781 Cr (up from ₹3,992 Cr in Q1 FY25) . Key concall takeaways from Trent Ltd's Q1 FY26 earnings call — and how…
- Aditya Birla Fashion & Retail Ltd (Q1 FY26)
Ethnic businesses posted a 25% revenue growth and sharp EBITDA margin expansion by 1600 bps with strong wedding season demand, signaling sustained…
- Crizac Ltd (Q1 FY26)
Management foresees sustaining margins around 25% and cost of services around 70% of revenue. Key concall takeaways from Crizac Ltd's Q1 FY26 earnings call…
- Aditya Birla Lifestyle Brands Ltd (Q1 FY26)
Working capital cycle stable between 13%-15% of sales, ensuring steady cash flow. Key concall takeaways from Aditya Birla Lifestyle Brands Ltd's Q1 FY26…
Arthneeti Pro · Annual
Entero Healthcare Solutions Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Entero Healthcare Solutions Ltd Q1 FY26 results?
Targeting 30% revenue growth in FY'26, combining both organic and inorganic growth. - Organic growth remains strong at around 15%, with inorganic contributing approximately 16%, summing to a like-for-like growth of 31%. - Acquisitions expected to contribute about Rs. Entero Healthcare Solutions targets 30% revenue growth in FY'26, combining organic and inorganic growth. - EBITDA margin guidance is 4%+ for the full year FY'26, with current Q1 margin at 3.6% expected to improve as revenue growth accelerates. - Operating leverage benefits will drive margin expansion as fixed costs are stable; salary hikes are already accounted for in Q1. - Gross margins improved by 83 bps YoY to 9.9%, with further procurement efficiencies and richer product mix expected. - Profit after tax increased 47% YoY to Rs.
What is Entero Healthcare Solutions Ltd share price analysis?
Entero Healthcare Solutions Ltd currently shows a neutral. The stock trades at a P/E of 46.3 with a market cap of ₹5,479 Cr. Investors should review the full earnings analysis for detailed insights.
Is Entero Healthcare Solutions Ltd planning capital expenditure?
Entero Healthcare has already made significant investments in proprietary technology, including building its own customizable ERP systems integrated with platforms like Facebook and WhatsApp, and customer-facing apps.
Keep Entero Healthcare Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.